A hypothetical "Callicebus moloch THOC2, partial" recombinant protein would likely:
Target regions: Domains implicated in RNA binding or complex stability (e.g., residues 1,400–1,593) .
Expression systems: Mammalian cells (e.g., HEK293) for proper post-translational modifications .
| Parameter | Specification |
|---|---|
| Species | Callicebus moloch (NCBI Taxonomy ID: 9499) |
| Construct length | Partial (e.g., 1,200–1,593 aa) |
| Tag | His-tag, FLAG, or GFP for purification |
| Purity | ≥90% (SDS-PAGE verified) |
Data from human and model organisms suggest conserved roles:
THOC2 depletion: Causes mRNA nuclear retention, mitotic defects, and neuronal dysfunction .
Pathogenic variants: Reduce protein stability (e.g., half-life of p.Ile800Thr THOC2: 1.7 hr vs. 8.0 hr wild type) .
| Variant | Half-life (hr) | TREX complex stability | Clinical phenotype |
|---|---|---|---|
| Wild-type | 8.0 | Stable | None |
| p.Leu438Pro (human) | 5.4 | Reduced | Syndromic intellectual disability |
| p.Ile800Thr (human) | 1.7 | Severely reduced | Severe developmental delay |
While no studies on Callicebus moloch THOC2 exist, human recombinant THOC2 has been used to:
Antibody validation: Anti-THOC2 antibodies (e.g., Proteintech 55178-1-AP) target epitopes in residues 1,400–1,593 .
Complex assembly assays: Study interactions with THOC1, THOC3, and Aly .
Species-specific data: No structural or functional studies on Callicebus moloch THOC2 are available.
Domain mapping: The exact "partial" region of the recombinant protein is undefined without experimental data.
To characterize recombinant Callicebus moloch THOC2:
THOC2 is the largest subunit of the highly conserved TREX (Transcription-Export) complex, functioning as a scaffold protein critical for TREX assembly and function. This 1,593-amino acid, 183-kDa nuclear protein plays essential roles in mRNA export from the nucleus to the cytoplasm. Beyond export functions, THOC2 participates in transcription, 3' mRNA processing, stress responses, mitotic progression, and maintaining genome stability . The functional TREX complex is co-transcriptionally loaded onto mRNAs and transfers mature transcripts to export adapters NXF1-NXT1 via ALYREF, ultimately exporting mRNAs to the cytoplasm through nuclear pores .
THOC2 forms part of the THO sub-complex (THOC1–3 and THOC5–7), which is an essential component of the larger TREX complex (consisting of THO, UAP56, Aly, CIP29, PDIP3, ZC11A, and Chtop) . Despite sharing a name, THO proteins do not share significant sequence similarity . Research has demonstrated that THOC2 depletion destabilizes other THO sub-complex proteins including THOC1, THOC3, THOC5, and THOC7, indicating its structural importance to the complex integrity . This makes THOC2 a critical scaffold protein that maintains the structural and functional integrity of the entire TREX assembly.
While limited specific information exists about THOC2 in Callicebus moloch (titi monkey), we know that THOC2 is highly conserved across species. Human THOC2 shares 98% amino acid identity with mouse THOC2 , suggesting high conservation among mammals. Callicebus moloch, as a neotropical primate of the family Pitheciidae , would likely have substantial homology with human THOC2, though species-specific variations may affect protein function or interaction capabilities. Researchers working with recombinant Callicebus moloch THOC2 should consider these potential differences when extrapolating findings to human systems.
For recombinant production of a large protein like THOC2 (183 kDa), mammalian expression systems are often preferred to ensure proper folding and post-translational modifications. Human embryonic kidney (HEK293) or Chinese hamster ovary (CHO) cells are recommended for maintaining native protein conformation. For partial THOC2 constructs, bacterial systems like E. coli BL21(DE3) may be suitable, particularly when expressing specific domains such as the RNA-binding regions. When using bacterial systems, consider fusion tags (His6, GST, or MBP) to enhance solubility and facilitate purification. Yeast expression systems may represent a compromise between proper eukaryotic processing and higher yields compared to mammalian systems.
A multi-step purification protocol is recommended for recombinant THOC2:
Initial Capture: Affinity chromatography using appropriate tag (His-tag or GST-tag)
Intermediate Purification: Ion exchange chromatography (typically anion exchange as THOC2 has a theoretical pI of 6.2)
Polishing Step: Size exclusion chromatography to remove aggregates and achieve high purity
For structural studies, consider including RNase treatment during purification to remove bound RNA that might affect homogeneity. When purifying THOC2 with mutations analogous to those found in patient studies (e.g., p.Leu313Phe, p.Leu438Pro variants), adjust protocols to account for potentially reduced stability, as these variants have demonstrated shorter half-lives (1.7-5.4 hours compared to ~8 hours for wild-type) .
Studying THOC2 protein-protein interactions presents several challenges:
Size and Complexity: At 183 kDa, full-length THOC2 is difficult to express and purify in its native conformation
Multiple Interaction Partners: THOC2 interacts with numerous TREX components (THOC1, THOC3, THOC5-7, UAP56, Aly, etc.)
Dynamic Interactions: TREX assembly is dynamic and context-dependent
Recommended approaches include:
Pull-down assays with tagged recombinant THOC2 fragments to identify interaction domains
Proximity labeling methods (BioID or APEX) to capture transient interactions
Crosslinking mass spectrometry (XL-MS) to map interaction interfaces
Surface plasmon resonance (SPR) to determine binding kinetics with purified partners
When designing experiments, consider that mutations in different domains may selectively disrupt specific protein interactions while preserving others, as observed in stability studies of THOC2 variants .
R-loops, three-stranded nucleic acid structures consisting of an RNA-DNA hybrid and displaced single-stranded DNA, accumulate when THOC2 function is compromised . To study this phenomenon:
In vitro R-loop formation assays: Use purified recombinant THOC2 (wild-type and variants) with model RNA-DNA templates to assess direct effects on R-loop resolution
DNA-RNA immunoprecipitation (DRIP): Compare R-loop accumulation in cell models with wild-type vs. mutant THOC2
Genome-wide mapping: Combine DRIP with high-throughput sequencing to identify R-loop hotspots affected by THOC2 dysfunction
The mouse model with Thoc2 exon 37-38 deletion demonstrated that compromised THOC2/TREX function leads to R-loop accumulation, DNA damage, and consequent cell death . When designing experiments, include appropriate controls for R-loop specificity (RNase H treatment) and consider both global R-loop levels and specific genomic regions of interest.
To characterize RNA-binding properties of recombinant Callicebus moloch THOC2:
RNA Electrophoretic Mobility Shift Assays (EMSA): To assess binding affinity to different RNA sequences
UV crosslinking: To map precise RNA-protein interaction sites
RNA Immunoprecipitation followed by Sequencing (RIP-seq): To identify preferred RNA targets in vivo
Structural analysis: Using partial constructs of RNA-binding domains
Focus particularly on the RNA-binding regions where disease-causing variants have been identified, including those corresponding to human p.Leu313Phe, p.Leu438Pro, and p.Tyr517Cys variants, which structural modeling has shown to be located in RNA-binding regions . The predicted THOC2 complex structures suggest two potential intermediate RNA-binding states during RNA transport .
Recombinant THOC2 can be instrumental in understanding neurodevelopmental processes given THOC2's high expression in developing and mature brain tissues :
Neural differentiation models: Use recombinant THOC2 to rescue phenotypes in THOC2-depleted neural stem cells
RNA export assays: Examine how THOC2 variants affect export of specific mRNAs important for neurodevelopment
Protein interaction studies: Identify neural-specific THOC2 interactors
The mouse model with Thoc2 exon 37-38 deletion exhibited significant neurodevelopmental phenotypes, including deficits in spatial learning, working memory, and sensorimotor functions . These phenotypes recapitulate those observed in patients with THOC2 syndrome, making this an excellent model system for studying the molecular mechanisms of neurodevelopmental disorders associated with THOC2 dysfunction.
| Issue | Potential Causes | Solutions |
|---|---|---|
| Low expression yield | Large protein size (183 kDa) | Use strong promoters (CMV for mammalian cells); Optimize codon usage |
| Protein degradation | Reduced stability of certain variants | Add proteasome inhibitors; Express at lower temperatures |
| Protein insolubility | Improper folding | Add solubility tags (MBP, SUMO); Use specialized folding strains |
| Function loss in recombinant protein | Missing post-translational modifications | Switch to eukaryotic expression systems |
| Heterogeneous product | Partial translation or degradation | Western blot analysis to confirm full-length product; Optimize purification |
When working with THOC2 variants analogous to those found in patients, be particularly aware of potential stability issues. The p.Leu438Pro and p.Ile800Thr variants have demonstrated significantly reduced stability with half-lives of 5.4 and 1.7 hours respectively, compared to approximately 8 hours for wild-type THOC2 .
When designing mRNA export assays using recombinant THOC2:
Positive controls:
Wild-type THOC2 protein to establish baseline function
Known efficient mRNA export substrates (e.g., β-actin mRNA)
Negative controls:
THOC2 with RNA-binding domain mutations
mRNAs known to be TREX-independent
Cells treated with nuclear export inhibitors (e.g., Leptomycin B)
Validation controls:
Subcellular fractionation quality controls (nuclear/cytoplasmic markers)
RNA integrity assessments
Protein expression level normalization
Research has shown that THOC2 depletion causes severe mRNA-export blockage , with the degree of blockage corresponding to THOC2 abundance levels. When designing rescue experiments with recombinant THOC2, ensure comparable expression levels to endogenous protein for physiologically relevant results.
Given the size and complexity of THOC2, a multi-method approach is recommended:
Structural modeling has revealed that disease-causing variants (p.Leu313Phe, p.Leu438Pro, p.Tyr517Cys) are located in RNA-binding regions, with two potential intermediate RNA-binding states of THOC2 identified during RNA transport . Focus structural studies on these regions to better understand how mutations affect THOC2 function.
Proteomics offers valuable insights into THOC2 function and interaction networks:
Quantitative interaction proteomics: Compare interactomes of wild-type vs. mutant THOC2 to identify affected pathways
Post-translational modification (PTM) mapping: Identify ubiquitylation, phosphorylation, and other modifications regulating THOC2
Protein turnover analysis: Pulse-chase experiments to study THOC2 stability and degradation pathways
Spatial proteomics: Determine subcellular localization changes of THOC2 and its partners
THOC2 is known to be ubiquitylated, and reduced protein levels of certain variants (p.Leu438Pro, p.Ile800Thr) are likely the result of enhanced proteasome-mediated degradation . Proteomic approaches can help identify the specific ubiquitin ligases and degradation pathways involved in THOC2 regulation.
Multiple model organisms have provided insights into THOC2 function with varying degrees of relevance:
When extrapolating findings to Callicebus moloch THOC2, consider evolutionary conservation. While core functions are likely preserved, species-specific differences may exist in tissue expression patterns, protein interactions, or regulatory mechanisms.
When selecting cell models for studying recombinant THOC2:
Primate cell lines: Most relevant but challenging to obtain
Callithrix jacchus (marmoset) fibroblasts as closest available option
Human cell lines: Next best alternative
Mouse cell models:
Patient-derived cells have been instrumental in understanding THOC2 function. Lymphoblastoid cell lines (LCLs) and skin fibroblasts from patients with THOC2 variants (e.g., p.Leu438Pro) showed decreased THOC2 protein levels and disrupted TREX complex stability , providing valuable models for studying THOC2 dysfunction.